M Henkelman1, W Kucharczyk. 1. Department of Medical Biophysics, University of Toronto, Ontario, Canada.
Abstract
PURPOSE: To determine optimal MR gradient-echo sequences for the visualization of calcium in neurologic MR. METHOD: The dependence of signal intensity and image contrast on the imaging parameters repetition time, echo time, flip angle, and spoiling were measured for hydroxyapatite samples. Calculations of signal intensity were shown to correspond to these measures. RESULTS: Optimum detectability was obtained with an echo time of 29 msec and was independent of spoiling. As repetition time ranged from 30 msec to 700 msec, the optimal flip angle ranged from 17 degrees to 66 degrees. CONCLUSIONS: Gradient-echo sequences that optimize the contrast for detection of calcium in neurologic imaging have been determined.
PURPOSE: To determine optimal MR gradient-echo sequences for the visualization of calcium in neurologic MR. METHOD: The dependence of signal intensity and image contrast on the imaging parameters repetition time, echo time, flip angle, and spoiling were measured for hydroxyapatite samples. Calculations of signal intensity were shown to correspond to these measures. RESULTS: Optimum detectability was obtained with an echo time of 29 msec and was independent of spoiling. As repetition time ranged from 30 msec to 700 msec, the optimal flip angle ranged from 17 degrees to 66 degrees. CONCLUSIONS: Gradient-echo sequences that optimize the contrast for detection of calcium in neurologic imaging have been determined.
Authors: R Bitar; A R Moody; S Symons; G Leung; S Crisp; A Kiss; A Nelson; R Maggisano Journal: AJNR Am J Neuroradiol Date: 2010-05-13 Impact factor: 3.825
Authors: L Liang; Y Korogi; T Sugahara; Y Shigematsu; T Okuda; I Ikushima; M Takahashi Journal: AJNR Am J Neuroradiol Date: 1999-09 Impact factor: 3.825
Authors: Steven M Greenberg; Meike W Vernooij; Charlotte Cordonnier; Anand Viswanathan; Rustam Al-Shahi Salman; Steven Warach; Lenore J Launer; Mark A Van Buchem; Monique Mb Breteler Journal: Lancet Neurol Date: 2009-02 Impact factor: 44.182